Basic and Clinical Neuroscience (Feb 2014)

Mu Opioid Receptor Gene: New Point Mutations in Opioid Addicts

  • Amin Dinarvand,
  • Ali Goodarzi,
  • Nasim Vousooghi,
  • Mehrdad Hashemi,
  • Rasoul Dinarvand,
  • Fahimeh Ostadzadeh,
  • Ahad Khoshzaban,
  • Mohammad-Reza Zarrindast

Journal volume & issue
Vol. 5, no. 1
pp. 18 – 21

Abstract

Read online

Introduction: Association between single-nucleotide polymorphisms (SNPs) in mu opioid receptor gene and drug addiction has been shown in various studies. Here, we have evaluated the existence of polymorphisms in exon 3 of this gene in Iranian population and investigated the possible association between these mutations and opioid addiction. Methods: 79 opioid-dependent subjects (55 males, 24 females) and 134 non-addict or control individuals (74 males, 60 females) participated in the study. Genomic DNA was extracted from volunteers’ peripheral blood and exon 3 of the mu opioid receptor gene was amplified by polymerase chain reaction (PCR) whose products were then sequenced. Results: Three different heterozygote polymorphisms were observed in 3 male individuals: 759T>C and 877G>A mutations were found in 2 control volunteers and 1043G>C substitution was observed in an opioid-addicted subject. Association between genotype and opioid addiction for each mutation was not statistically significant. Discussion: It seems that the sample size used in our study is not enough to confirm or reject any association between 759T>C, 877G>A and 1043G>C substitutions in exon 3 of the mu opioid receptor gene and opioid addiction susceptibility in Iranian population.

Keywords